Details for 2020162150
Up to date per 02.04.2026
Actions
Details for 2020162150
Granted/Registered
European Patent
02.09.2020 A
26.10.2022 B1
31.05.2016
US
201662343840 P
A61L 15/38 20060101AFI20200729BHEP
Owner
Octapharma AGSeidenstraße 2 8853 LachenCH
Representative
Representative
Dipl.-Ing.Werner Barger, Dipl.-Ing. Dr. techn. Peter IsrailoffOperngasse 41010 WienAT
Inventor
Ericson, Daniel Grant1423 Bell Oaks Lane Rochester, 55902-1312US
Information about Fees